[14 pharmaceutical-themed funds all earn more than 10% this year, institutions are still optimistic about late-stage investment opportunities]-since the beginning of this year, the biomedical sector is still highly favored by institutions, and a number of pharmaceutical-themed funds have achieved outstanding returns this year. According to data, as of June 1, 14 medical-themed funds had earned more than 10% of their income this year, with the highest return reaching 42.8%. A number of public funds believe that the medical theme fund performed well during the year, although the overall performance is differentiated, but from the perspective of future investment opportunities, it is still a better direction of asset allocation. (Securities Daily)